Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
The latest announcement is out from Pro Medicus Limited ( (AU:PME) ).
Pro Medicus Limited has announced an update on its ongoing on-market buy-back program, revealing the acquisition of 2,518 ordinary fully paid securities on the previous day, adding to a total of 2,520 securities bought back prior. This buy-back initiative is part of the company’s strategy to manage its capital structure and potentially enhance shareholder value, reflecting a proactive approach in maintaining its market positioning.
More about Pro Medicus Limited
Pro Medicus Limited operates in the healthcare technology industry, providing advanced imaging software and services primarily for the medical sector. The company focuses on delivering innovative solutions that enhance the efficiency and effectiveness of medical imaging processes.
YTD Price Performance: -19.58%
Average Trading Volume: 479
Technical Sentiment Signal: Sell
Current Market Cap: $13.13B
Learn more about PME stock on TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue